Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

15,000 skin patients enrolled in massive Real-World treatment study

NCT ID NCT03661866

Knowledge-focused Sponsor: Target PharmaSolutions, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 15,000 adults and children with skin conditions like eczema, psoriasis, and vitiligo to see how well current and new treatments work in real doctor visits. It does not test a new drug but instead collects information to help doctors understand which treatments are safest and most effective over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 15,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2018

Expected to finish

Dec 2050

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults and children (all ages) with with Atopic Dermatitis or other IMISC been prescribed any dermatologic treatment.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 1\. Adults and children (all ages) with Atopic Dermatitis or other Immune-mediated Inflammatory Skin Conditions been prescribed any dermatologic treatment. * 2\. Participant has plans for future visits at the site for continued management of IMISC. Exclusion Criteria: * 1\. Inability to provide written informed consent/assent. * 2\. Subjects participating in any interventional study or trial for IMISC treatment trial at the time of enrollment. Patients may be enrolled in TARGET-DERM once participation in the trial is complete. Note: Participants may be enrolled in other registries or studies where IMISC treatment outcomes are observed and/or reported (such as center-based registries).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Alopecia areata are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

alopecia areata atopic eczema chronic idiopathic urticaria Chronic Urticaria hidradenitis suppurativa psoriasis vitiligo

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Alopecia areata Atopic dermatitis Chronic spontaneous urticaria Hidradenitis suppurativa Psoriasis Vitiligo

Contacts and locations

Locations

  • Academic Alliance in Dermatology

    Tampa, Florida, 33614, United States

  • Advanced Allergy & Asthma, PLLC

    Rockville Centre, New York, 11570, United States

  • Advanced Dermatology of the Midlands

    Omaha, Nebraska, 68144, United States

  • Allergy Associates of Utah

    Murray, Utah, 84107, United States

  • Allergy Partners of Western North Carolina

    Asheville, North Carolina, 28801, United States

  • Allergy and Clinical Immunology

    Pittsburgh, Pennsylvania, 15241, United States

  • Allergy, Asthma & Clinical Research Center

    Oklahoma City, Oklahoma, 73120, United States

  • Arkansas Dermatology

    Little Rock, Arkansas, 72223, United States

  • Asthma and Allergy Center

    Lewisville, Texas, 75067, United States

  • Carl Thornblade, MD, PLLC

    Missoula, Montana, 59808, United States

  • Center for Clinical Studies

    Webster, Texas, 77598, United States

  • Center for Dermatology Cosmetic and Laser Surgery

    Fremont, California, 94538, United States

  • Centurion Dermatology

    Brooklyn, New York, 11219, United States

  • Children's Hospital of Wisconsin

    Milwaukee, Wisconsin, 53226, United States

  • Clear Dermatology & Aesthetics Center/Investigative MD

    Scottsdale, Arizona, 85255, United States

  • Dartmouth-Hitchcock Medical Center

    Lebanon, New Hampshire, 03756, United States

  • Dawes Fretzin Dermatology/ Dawes Fretzin Clinical Research Group

    Indianapolis, Indiana, 46520, United States

  • DermAssociates, LCC

    Rockville, Maryland, 20850, United States

  • Dermatology Center for Skin Health

    Morgantown, West Virginia, 26542, United States

  • Dr. Bernhard Korge

    Düren, North Rhine-Westphalia, 52349, Germany

  • El Paso Dermatology Center

    El Paso, Texas, 79902, United States

  • Empire Dermatology

    East Syracuse, New York, 13057, United States

  • Family Allergy and Asthma Research Institute

    Louisville, Kentucky, 40215, United States

  • Feinstein Dermatology and Cosmetic Surgery

    Hollywood, Florida, 33021, United States

  • First OC Dermatology

    Fountain Valley, California, 92708, United States

  • Forest Hills Dermatology Group

    Forest Hills, New York, 11375, United States

  • George Washington University

    Washington D.C., District of Columbia, 20037, United States

  • Greenwich Village Dermatology

    New York, New York, 10012, United States

  • Hospital Clinic de Barcelona

    Barcelona, Spain

  • Hospital Universitario La Princesa

    Madrid, Spain

  • Ichan School of Medicine

    New York, New York, 10029, United States

  • Innovaderm Research, Inc.

    Montreal, Quebec, Canada

  • Integrated Dermatology of Massachusetts

    Quincy, Massachusetts, 02169, United States

  • Integrated Dermatology of West Palm Beach

    West Palm Beach, Florida, 33406, United States

  • Johnson Dermatology

    Fort Smith, Arkansas, 72916, United States

  • Linda Susan Marcus

    Wyckoff, New Jersey, 07481, United States

  • Lurie Children's Hospital/Northwestern University

    Chicago, Illinois, 60611, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • Montefiore Medical Center

    The Bronx, New York, 10467, United States

  • North Sound Dermatology

    Mill Creek, Washington, 98012, United States

  • North Texas Center for Clinical Research

    Frisco, Texas, 75034, United States

  • Ohio State University

    Columbus, Ohio, 43215, United States

  • Oregon Health and Science University

    Portland, Oregon, 97239, United States

  • Saskatoon Dermatology Centre

    Saskatoon, Saskatchewan, Canada

  • Skin Centre for Dermatology

    Peterborough, Ontario, Canada

  • South Lincoln Dermatology Clinic

    Lincoln, Nebraska, 68502, United States

  • Spokane Dermatology Clinic

    Spokane, Washington, 99202, United States

  • The Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • The University of Buffalo

    Buffalo, New York, 14203, United States

  • The University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

  • UKSH- Institut für Entzündungsmedizin

    Lübeck, Schleswig-Holstein, 23538, Germany

  • UNC Dermatology

    Chapel Hill, North Carolina, 27516, United States

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, 72205, United States

  • University of California

    Irvine, California, 92697, United States

  • University of California - San Diego/Rady Children's Hospital

    San Diego, California, 92123, United States

  • University of Massachusetts Medical School

    Worcester, Massachusetts, 01605, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55455, United States

  • University of Utah MidValley Dermatology

    Murray, Utah, 84107, United States

  • Virginia Commonwealth University

    Richmond, Virginia, 23219, United States

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157, United States

  • Windsor Dermatology

    East Windsor, New Jersey, 08520, United States

  • York Dermatology Clinic and Research Centre

    Richmond Hill, Ontario, L4B 1L1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.